Vancouver, BC – 360 Capital Financial Services Group Inc. (“360 Capital” or the “Company”) (CSE:TSZ, www.360capital.ca) announced today that the Board has appointed Mr. David Stadnyk as the new President and CEO, and as a new Director.
Mr. David Stadnyk is the Founder of Supreme Pharmaceuticals Inc., and Stadnyk and Partners Family Offices & Venture Capital. He has more than 25 years of investment banking experience and has been involved in raising over $500 million in equity capital funds. Mr. Stadnyk has extensive knowledge in the public capital markets and strong relationships with global investment banks and independent boutique investment dealers. David has founded multiple companies and has provided a variety of leadership, investment and developmental roles in the biotech, pharmaceuticals and resource sectors.
With the appointment of Mr. Stadnyk as President and CEO, Mr. John Gan will assume the role of Executive Vice-President and remain a Director. Having built a solid foundation as a diversified financial services company and now with Mr. Stadnyk at the helm, 360 Capital is perfectly positioned to continue to implement its business plan and to expand its objectives.
360 Capital is undertaking to identify new investment opportunities in the Marijuana business sector, while continuing to fulfill its current business objectives. The Company is poised to benefit from Mr. Stadnyk’s considerable expertise in investment banking and raising capital, in combination with his successful track record in the Marijuana business sector.
About 360 Capital Financial Services Group Inc.
360 Capital Financial Services Group (CSE:TSZ, www.360capital.ca), through our subsidiaries and affiliated companies, provides a broad range of financial services to emerging private and public companies. We “Connect Capital to Growth” by providing corporate finance advisory, merchant banking, IPO consulting and business advisory services for our clients.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Ullrich Schade, Corporate Communications
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, dependence upon regulatory and shareholder approvals, the execution of definitive documentation and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise.